IL10 and breast carcinoma: Cisplatin-treated rats exhibited significantly increased levels of TNF-α (p < 0.001), IL-6 (p < 0.01), and IL-8 (p < 0.001) whereas, significantly decreased the level of IL-10 (p < 0.01) on the 5th day when compared with breast cancer control rats.